VistaGen Therapeutics logo
VistaGen Therapeutics VTGN
$ 2.52 -0.59%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

VistaGen Therapeutics EV/EBITDA Ratio 2011-2024 | VTGN

Annual EV/EBITDA Ratio VistaGen Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.0377 -0.87 -0.716 -0.253 -1.18 -0.824 -3.7 -3.51 -3.05 -4.45 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.0377 -4.45 -1.85